In addition, patients with NOD2 polymorphisms are reportedly at high risk of lymphoma, colorectal cancer, gastric cancer, breast cancer, ovarian cancer, lung cancer, and laryngeal cancer, but at low risk of kidney cancer [32]. Here, NOD2 is linked to breast cancer.